Deepening expertise in endocrine and metabolic chronic disease management and drug development
Endocrine and metabolic diseases are chronic systemic conditions with extremely high global prevalence, requiring long-term or even lifelong management. These diseases not only cause hormonal imbalance and metabolic disorders, but are also highly prone to triggering severe systemic target organ complications affecting the cardiovascular system, kidneys, nervous system, and fundus oculi, severely impacting patients' quality of life.
Leveraging an extensive endocrinology expert network, Guangzhou Evidence-Based Medicine precisely screens and expands into hospitals in second- and third-tier cities with abundant patient pools, overcoming common challenges such as fierce project competition and uneven geographic distribution of enrollment. Targeting the long-term medication characteristics of chronic diseases, we have established subject compliance management systems and rigorously scrutinize key quality control points such as patients' prior medication history, ensuring high-quality trial data and smooth project delivery.
With a professional and efficient service system and a comprehensive operational network, Guangzhou Evidence Based Medicine is committed to providing tailored one-stop traditional Chinese medicine research and development full industry chain service solutions for every customer, promoting traditional Chinese medicine to the world and safeguarding the health of more people.
